These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 19293769

  • 1. Breast cancer therapy: the role of PET-CT in decision making.
    Pons F, Duch J, Fuster D.
    Q J Nucl Med Mol Imaging; 2009 Apr; 53(2):210-23. PubMed ID: 19293769
    [Abstract] [Full Text] [Related]

  • 2. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M.
    J Clin Oncol; 2009 Jul 10; 27(20):3303-11. PubMed ID: 19451443
    [Abstract] [Full Text] [Related]

  • 3. The role of 18F-FDG PET in assessing therapy response in cancer of the cervix and ovaries.
    Schwarz JK, Grigsby PW, Dehdashti F, Delbeke D.
    J Nucl Med; 2009 May 10; 50 Suppl 1():64S-73S. PubMed ID: 19380409
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment.
    Bastiaannet E, Wobbes T, Hoekstra OS, van der Jagt EJ, Brouwers AH, Koelemij R, de Klerk JM, Oyen WJ, Meijer S, Hoekstra HJ.
    J Clin Oncol; 2009 Oct 01; 27(28):4774-80. PubMed ID: 19720925
    [Abstract] [Full Text] [Related]

  • 8. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H, Fury M, Lee N, Kraus D.
    J Nucl Med; 2009 May 01; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [Abstract] [Full Text] [Related]

  • 9. The evolving role of PET-CT in the management of esophageal cancer.
    Chuang HH, Macapinlac HA.
    Q J Nucl Med Mol Imaging; 2009 Apr 01; 53(2):201-9. PubMed ID: 19293768
    [Abstract] [Full Text] [Related]

  • 10. Assessing tumor response to therapy.
    Weber WA.
    J Nucl Med; 2009 May 01; 50 Suppl 1():1S-10S. PubMed ID: 19380403
    [Abstract] [Full Text] [Related]

  • 11. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
    Malone JP, Gerberi MA, Vasireddy S, Hughes LF, Rao K, Shevlin B, Kuhn M, Collette D, Tennenhouse J, Robbins KT.
    Arch Otolaryngol Head Neck Surg; 2009 Nov 01; 135(11):1119-25. PubMed ID: 19917925
    [Abstract] [Full Text] [Related]

  • 12. [18F]FDG-PET-CT for early monitoring of tumor response: when and why.
    Storto G, Nicolai E, Salvatore M.
    Q J Nucl Med Mol Imaging; 2009 Apr 01; 53(2):167-80. PubMed ID: 19293765
    [Abstract] [Full Text] [Related]

  • 13. Assessing short-term effects and costs at an early stage of innovation: the use of positron emission tomography on radiotherapy treatment decision making.
    Remonnay R, Morelle M, Pommier P, Giammarile F, Carrère MO.
    Int J Technol Assess Health Care; 2008 Apr 01; 24(2):212-20. PubMed ID: 18400125
    [Abstract] [Full Text] [Related]

  • 14. PET/CT for therapy response assessment in lymphoma.
    Hutchings M, Barrington SF.
    J Nucl Med; 2009 May 01; 50 Suppl 1():21S-30S. PubMed ID: 19380407
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular PET/CT imaging-guided radiation therapy treatment planning.
    Zaidi H, Vees H, Wissmeyer M.
    Acad Radiol; 2009 Sep 01; 16(9):1108-33. PubMed ID: 19427800
    [Abstract] [Full Text] [Related]

  • 17. PET-CT for treatment planning in prostate cancer.
    Picchio M, Crivellaro C, Giovacchini G, Gianolli L, Messa C.
    Q J Nucl Med Mol Imaging; 2009 Apr 01; 53(2):245-68. PubMed ID: 19293771
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
    Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA.
    J Nucl Med; 2009 Aug 01; 50(8):1205-13. PubMed ID: 19617339
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.